| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Shuxiang Li CEO | SSE Exchange | CNE000001840 ISIN |
| CN Country | 2,678 Employees | 14 Jul 2026 Last Dividend | 26 May 2006 Last Split | 24 May 2001 IPO Date |
Tianjin Tianyao Pharmaceuticals Co., Ltd., established in 1999 and headquartered in Tianjin, China, focuses on the research, development, production, and sales of pharmaceutical products, particularly corticosteroids, amino acid active pharmaceutical ingredients (APIs), and a variety of medical preparations. The firm has marked its presence not only in China but also across multiple international markets, including the United States, Southeast Asia, Europe, South America, and Africa. Operating under the larger umbrella of Tianjin Pharmaceutical Group Co., Ltd., Tianjin Tianyao Pharmaceuticals has built a reputation for specializing in a critical segment of the pharmaceutical industry.